Premium
Lower urinary tract symptoms in patients with N iigata M inamata disease: A case–control study 50 years after methyl mercury pollution
Author(s) -
Hara Noboru,
Saito Hisashi,
Takahashi Kota,
Takeda Masayuki
Publication year - 2013
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/iju.12001
Subject(s) - medicine , overactive bladder , lower urinary tract symptoms , urinary system , international prostate symptom score , urology , disease , gastroenterology , prostate , gynecology , pathology , alternative medicine , cancer
Objectives To clarify the prevalence of lower urinary tract symptoms and overactive bladder in patients with chronic methyl mercury poisoning. Methods A total of 151 patients (61 men and 90 women; mean age 72.1 years) with N iigata M inamata disease were enrolled. An age‐ and sex‐matched group of 150 participants was used as control. Patients reported their International Prostate Symptom Score and overactive bladder symptom score. Results In men, the total, storage and voiding International Prostate Symptom Score scores were higher in the N iigata M inamata disease group than in the control group (10.6 ± 7.8 vs 5.0 ± 5.0, 4.5 ± 3.3 vs 2.4 ± 2.4 and 6.1 ± 5.1 vs 2.7 ± 3.1, respectively, P < 0.001 in all). In women, these scores were also higher in the N iigata M inamata disease group than in the control group (8.9 ± 7.3 vs 4.0 ± 4.0, 4.4 ± 3.2 vs 2.8 ± 2.4 and 4.5 ± 5.0 vs 1.3 ± 2.0, respectively, P < 0.001 in all). The prevalence of overactive bladder was more frequent in the N iigata M inamata disease group compared with that in the control group (51.7% vs 26.7%, P < 0.001). In both men and women, the overactive bladder symptom score was higher in the N iigata M inamata disease group than in the control group (4.1 ± 3.0 vs 2.4 ± 2.9, P = 0.002 and 4.6 ± 3.6 vs 2.7 ± 2.9, P < 0.001, respectively). The International Prostate Symptom Score and overactive bladder symptom score in the N iigata M inamata disease group were highest in patients aged 60–69 years ( P < 0.001 in both), whereas these increased in an age‐dependent manner in the control group. Conclusions Lower urinary tract symptoms and overactive bladder are severe and highly prevalent conditions among patients with methyl mercury poisoning. The higher prevalence of lower urinary tract symptoms among patients aged 60–69 years might be related to the fact that they were exposed to methyl mercury during their childhood/development.